Key result
Chronic heart failure is linked to ~189% higher all-cause mortality versus matched controls.
Why the study?
The study aimed to examine cardiovascular events, mortality, early retirement, and economic costs over 5 years in individuals with chronic heart failure compared with matched controls in Sweden.
Does chronic heart failure increase the risk of cardiovascular events, mortality, early retirement, and economic costs compared to matched controls?
Cohort (n=107,040)
Yes
Does chronic heart failure increase the risk of cardiovascular events, mortality, early retirement, and economic costs compared to matched controls?
Chronic heart failure is associated with a substantially increased risk of cardiovascular events, mortality, early retirement, and economic costs, driven largely by inpatient admissions and work absence.
Answers are grounded in this paper and cite their sources.
Supports closer monitoring in CHF; extends observational mortality and retirement data but leaves causal inference open for trials.
AIMS: We aimed to examine cardiovascular events (stroke and myocardial infarction [MI]), mortality, early retirement and economic costs over 5 years in people with chronic heart failure (CHF) and matched controls in Sweden. METHODS AND RESULTS: Individuals (aged ≥16 years) living in Sweden on 1 January 2012 were identified in an existing database. Individuals with CHF were propensity score matched to controls without CHF by birth year, sex and educational status. We analysed risks of stroke, MI, mortality and early retirement, and compared direct costs (inpatient care, outpatient care and drug costs) and indirect costs (work absence). After matching, there were 53 520 individuals in each cohort. In each cohort, mean age was 69.0 years (standard deviation 8.2), and 29.7% of individuals were women. People with CHF were significantly more likely than controls to experience stroke (hazard ratio 1.46 [95% confidence interval 1.38-1.56]) and MI (1.61 [1.51-1.71]). All-cause mortality was nearly three-fold higher (2.89 [2.80-2.98]) and the likelihood of early retirement was more than three-fold higher (3.69 [3.08-4.42]). Total mean annual costs per person were €9663 (standard error 38) for people with CHF, of which 53% were direct costs, and €2845 (standard error 19) for controls, of which 40% were direct costs. In people with CHF, inpatient costs comprised 78% of total annual mean direct costs over follow-up, outpatient costs contributed 15% and drug costs contributed 8%. In controls, the corresponding proportions were 71%, 18% and 11%. CONCLUSIONS: CHF has a considerable impact on the risk of cardiovascular events and death, early retirement and economic costs. Inpatient admissions and work absence are major contributors to economic costs.
No takes yet. Share an insight, caveat, or question.
Carlsson et al. (2023) conducted a cohort in Chronic heart failure (n=107,040). Chronic heart failure vs. Matched controls without chronic heart failure was evaluated on All-cause mortality (HR 2.89, 95% CI 2.80-2.98). Chronic heart failure was associated with a nearly three-fold higher risk of all-cause mortality and increased risks of cardiovascular events and early retirement compared to matched controls.
Synapse has enriched 10 related papers. Consider them for comparative context: